Vicarious Surgical Inc. (OTCMKTS:RBOT – Get Free Report) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totaling 63,698 shares, a decrease of 63.6% from the September 30th total of 175,182 shares. Based on an average daily volume of 44,757 shares, the short-interest ratio is currently 1.4 days. Currently, 1.0% of the shares of the stock are short sold.
Vicarious Surgical Price Performance
Shares of RBOT stock traded down $0.01 on Friday, hitting $0.01. 2,648 shares of the company’s stock were exchanged, compared to its average volume of 32,091. Vicarious Surgical has a 12 month low of $0.00 and a 12 month high of $5.50. The stock has a market cap of $60,554.00, a P/E ratio of -0.00 and a beta of 2.15. The company has a 50 day moving average of $0.05 and a 200 day moving average of $0.66.
Vicarious Surgical Company Profile
Vicarious Surgical, Inc is a technology company developing robotic-assisted surgical systems. Its principal product is the Vicarious Surgical System, a single-port robotic platform designed to enable surgeons to perform minimally invasive procedures through a small incision. The system combines miniature instruments, a high-resolution camera and digital controls intended to provide surgeons with an immersive view of the operating field and precise instrument control.
The company’s technology is aimed initially at general surgery applications, including procedures performed within the abdominal cavity.
See Also
- Five stocks we like better than Vicarious Surgical
- Starbucks Says Its Turnaround Is DoneāThe Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
